Literature DB >> 29131438

Melanoma tumors exhibit a variable but distinct metabolic signature.

René G Feichtinger1, Roland Lang2, Reinhard Geilberger1, Florian Rathje1, Johannes A Mayr3, Wolfgang Sperl3, Johann W Bauer2, Cornelia Hauser-Kronberger4, Barbara Kofler1, Michael Emberger5.   

Abstract

The Warburg theory of cancer postulates that an important driver of tumorigenesis is insufficient respiration due to mitochondrial defects, and concomitant enhancement of lactate production due to increased aerobic glycolysis. We analysed 48 melanoma samples by immunohistochemistry and found that 38% of melanomas are characterized by areas of isolated or combined deficiencies of complexes of the oxidative phosphorylation (OXPHOS) system, whereby the incidence of OXPHOS-deficient areas is associated with an increased Breslow index; 62% of melanomas showed high expression of all OXPHOS complexes. Expression of carbonic anhydrase IX was low, indicating that melanomas generally are well-oxygenated. Expression of HIF-1α and MCT4 was high, which might be a consequence of increased lactate dehydrogenase A levels in melanomas. Our data indicate that there are two types of melanomas: one that features a classic Warburg effect, whereas the other one, despite being glycolytic, maintains a high level of OXPHOS complexes.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Glycolysis; OXPHOS complexes; Warburg effect; hypoxia

Mesh:

Substances:

Year:  2018        PMID: 29131438     DOI: 10.1111/exd.13465

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  10 in total

1.  Increased formation of reactive oxygen species during tumor growth: Ex vivo low-temperature EPR and in vivo bioluminescence analyses.

Authors:  Gang Cheng; Jing Pan; Radoslaw Podsiadly; Jacek Zielonka; Alexander M Garces; Luiz Gabriel Dias Duarte Machado; Brian Bennett; Donna McAllister; Michael B Dwinell; Ming You; Balaraman Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2019-12-23       Impact factor: 7.376

2.  Ketogenic diets slow melanoma growth in vivo regardless of tumor genetics and metabolic plasticity.

Authors:  Daniela D Weber; Sepideh Aminzadeh-Gohari; Maheshwor Thapa; Anna-Sophia Redtenbacher; Luca Catalano; Tânia Capelôa; Thibaut Vazeille; Michael Emberger; Thomas K Felder; René G Feichtinger; Peter Koelblinger; Guido Dallmann; Pierre Sonveaux; Roland Lang; Barbara Kofler
Journal:  Cancer Metab       Date:  2022-07-18

Review 3.  Rethinking the biology of metastatic melanoma: a holistic approach.

Authors:  Hendrik Hld Vandyck; Lisa M Hillen; Francesca M Bosisio; Joost van den Oord; Axel Zur Hausen; Véronique Winnepenninckx
Journal:  Cancer Metastasis Rev       Date:  2021-04-19       Impact factor: 9.264

4.  Reduced Levels of ATP Synthase Subunit ATP5F1A Correlate with Earlier-Onset Prostate Cancer.

Authors:  René G Feichtinger; Georg Schäfer; Christof Seifarth; Johannes A Mayr; Barbara Kofler; Helmut Klocker
Journal:  Oxid Med Cell Longev       Date:  2018-11-14       Impact factor: 6.543

5.  Hypoxia potentiates the capacity of melanoma cells to evade cisplatin and doxorubicin cytotoxicity via glycolytic shift.

Authors:  Ming Zhuo; Falih M Gorgun; Douglas S Tyler; Ella W Englander
Journal:  FEBS Open Bio       Date:  2020-04-14       Impact factor: 2.693

Review 6.  Ketogenic diet in the treatment of cancer - Where do we stand?

Authors:  Daniela D Weber; Sepideh Aminzadeh-Gohari; Julia Tulipan; Luca Catalano; René G Feichtinger; Barbara Kofler
Journal:  Mol Metab       Date:  2019-07-27       Impact factor: 7.422

7.  Targeted Metabolomics Identifies Plasma Biomarkers in Mice with Metabolically Heterogeneous Melanoma Xenografts.

Authors:  Daniela D Weber; Maheshwor Thapa; Sepideh Aminzadeh-Gohari; Anna-Sophia Redtenbacher; Luca Catalano; René G Feichtinger; Peter Koelblinger; Guido Dallmann; Michael Emberger; Barbara Kofler; Roland Lang
Journal:  Cancers (Basel)       Date:  2021-01-23       Impact factor: 6.639

Review 8.  Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.

Authors:  Ahmad Najem; Laura Soumoy; Malak Sabbah; Mohammad Krayem; Ahmad Awada; Fabrice Journe; Ghanem E Ghanem
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

Review 9.  Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities.

Authors:  René G Feichtinger; Roland Lang
Journal:  J Oncol       Date:  2019-11-03       Impact factor: 4.375

10.  Targeting Mitochondria in Melanoma.

Authors:  Sepideh Aminzadeh-Gohari; Daniela D Weber; Luca Catalano; René G Feichtinger; Barbara Kofler; Roland Lang
Journal:  Biomolecules       Date:  2020-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.